Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)
Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –
Actinium Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Actinium Pharmaceuticals's cash was $36.47M at Jun 30, 2026. For fiscal 2025 it was $48.00M, down 34.5% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $109.61M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.00M | -34.5% |
| FY2024 | Dec 31, 2024 | $73.23M | -4.9% |
| FY2023 | Dec 31, 2023 | $76.99M | -29.8% |
| FY2022 | Dec 31, 2022 | $109.61M | +40.1% |
| FY2021 | Dec 31, 2021 | $78.22M | +22.2% |
| FY2020 | Dec 31, 2020 | $64.00M | +560.3% |
| FY2019 | Dec 31, 2019 | $9.69M | -31.3% |
| FY2018 | Dec 31, 2018 | $14.11M | -20.7% |
| FY2017 | Dec 31, 2017 | $17.79M | -13.3% |
| FY2016 | Dec 31, 2016 | $20.52M | -20.1% |
| FY2015 | Dec 31, 2015 | $25.68M | +282.9% |
| FY2014 | Dec 31, 2014 | $6.71M | +21.2% |
| FY2013 | Dec 31, 2013 | $5.53M | -1.5% |
| FY2012 | Dec 31, 2012 | $5.62M | -1.5% |
| FY2011 | Dec 31, 2011 | $5.70M | +2808.1% |
| FY2010 | Dec 31, 2010 | $196.14K | +9142.9% |
| FY2009 | Dec 31, 2009 | $2.12K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.47M | -39.5% |
| Q1 FY2026 | Mar 31, 2026 | $42.13M | -35.8% |
| Q4 FY2025 | Dec 31, 2025 | $48.00M | -34.5% |
| Q3 FY2025 | Sep 30, 2025 | $53.39M | -32.4% |
| Q2 FY2025 | Jun 30, 2025 | $60.26M | -30.2% |
| Q1 FY2025 | Mar 31, 2025 | $65.65M | -22.2% |
| Q4 FY2024 | Dec 31, 2024 | $73.23M | -4.9% |
| Q3 FY2024 | Sep 30, 2024 | $78.98M | -5.2% |
| Q2 FY2024 | Jun 30, 2024 | $86.36M | -5.7% |
| Q1 FY2024 | Mar 31, 2024 | $84.37M | -11.4% |
| Q4 FY2023 | Dec 31, 2023 | $76.99M | -29.8% |
| Q3 FY2023 | Sep 30, 2023 | $83.29M | -26.0% |
| Q2 FY2023 | Jun 30, 2023 | $91.58M | -21.5% |
| Q1 FY2023 | Mar 31, 2023 | $95.23M | +31.5% |
| Q4 FY2022 | Dec 31, 2022 | $109.61M | +40.1% |
| Q3 FY2022 | Sep 30, 2022 | $112.51M | +36.4% |
| Q2 FY2022 | Jun 30, 2022 | $116.72M | +41.7% |
| Q1 FY2022 | Mar 31, 2022 | $72.41M | -0.4% |
| Q4 FY2021 | Dec 31, 2021 | $78.22M | +22.2% |
| Q3 FY2021 | Sep 30, 2021 | $82.47M | +69.4% |
| Q2 FY2021 | Jun 30, 2021 | $82.35M | +52.8% |
| Q1 FY2021 | Mar 31, 2021 | $72.69M | +1039.2% |
| Q4 FY2020 | Dec 31, 2020 | $64.00M | +560.3% |
| Q3 FY2020 | Sep 30, 2020 | $48.67M | +229.9% |
| Q2 FY2020 | Jun 30, 2020 | $53.91M | +169.5% |
| Q1 FY2020 | Mar 31, 2020 | $6.38M | -38.4% |
| Q4 FY2019 | Dec 31, 2019 | $9.69M | -31.3% |
| Q3 FY2019 | Sep 30, 2019 | $14.75M | -0.4% |
| Q2 FY2019 | Jun 30, 2019 | $20.00M | -8.7% |
| Q1 FY2019 | Mar 31, 2019 | $10.36M | -61.9% |
| Q4 FY2018 | Dec 31, 2018 | $14.11M | -20.7% |
| Q3 FY2018 | Sep 30, 2018 | $14.81M | -27.9% |
| Q2 FY2018 | Jun 30, 2018 | $21.91M | +84.9% |
| Q1 FY2018 | Mar 31, 2018 | $27.19M | +59.1% |
| Q4 FY2017 | Dec 31, 2017 | $17.79M | -13.3% |
| Q3 FY2017 | Sep 30, 2017 | $20.54M | +32.3% |
| Q2 FY2017 | Jun 30, 2017 | $11.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.09M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.52M | – |
| Q3 FY2016 | Sep 30, 2016 | $15.53M | – |
See a number that looks wrong?